MetLife, Inc. (MET) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue contracted from $47.15B (period ending 2007-12-31) to $2.44B (period ending 2025-12-31) — a -15.2% annual pace across 18 year(s) of filed history.
- Net margin expanded from 9.2% to 138.7% over that same span.
- Across 55 tracked quarters, the strongest was $20.46B (quarter ending 2011-09-30) and the weakest was $313.0M (quarter ending 2019-09-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $2.44B | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Operating income | $6.14B | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Net income | $3.38B | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Diluted EPS | $4.71 | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Total assets | $745.17B | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Total liabilities | $716.25B | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Cash & equivalents | $22.03B | 2025-12-31 | 10-K | 0001099219-26-000013 |
| Operating cash flow | $17.09B | 2025-12-31 | 10-K | 0001099219-26-000013 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $724.0M | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Operating income | $1.60B | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Net income | $736.0M | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Diluted EPS | $1.09 | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Total assets | $759.37B | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Total liabilities | $731.41B | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Cash & equivalents | $19.30B | 2026-06-30 | 10-Q | 0001099219-26-000050 |
| Operating cash flow | $2.69B | 2026-03-31 | 10-Q | 0001099219-26-000035 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
MetLife, Inc. (MET) operates on a substantial scale, with total assets amounting to $745.17 billion as of the end of 2025, and this figure has grown to $759.37 billion by the end of Q2 2026. The company’s mix is predominantly insurance-focused, evident from its revenue streams. Over the past 18 years, MetLife’s revenue has contracted at an annual pace of -15.2%, shrinking from $47.15 billion in 2007 to $2.44 billion in 2025. This drastic reduction underscores a significant transformation in the company’s business model or market conditions.
Despite the revenue decline, MetLife has seen an expansion in its net margin from 9.2% to an impressive 138.7% over the same period. This indicates improved profitability relative to sales, suggesting operational efficiency gains or changes in the composition of revenues and expenses. The company’s operating income has also shown resilience, increasing from $6.98 billion in 2010 to $6.14 billion in 2025, although it dipped to $1.60 billion in Q2 2026.
In the next filing, readers should monitor MetLife’s ability to sustain profitability amidst declining revenues and assess whether the current net margin expansion is a temporary anomaly or indicative of a structural shift. Additionally, tracking changes in operating cash flow will be crucial, as it provides insight into the company’s underlying operational health and its capacity to fund future growth or dividends. The fluctuation between $17.09 billion in 2025 and $2.69 billion in Q1 2026 warrants close attention for signs of sustainability or potential liquidity concerns.
Source: SEC EDGAR company facts for CIK 0001099219 · filings index